According to Paratek Pharmaceuticals 's latest financial reports the company's total liabilities are $0.34 B. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2022-12-31 | $0.34 B | 10.24% |
2021-12-31 | $0.31 B | 11.66% |
2020-12-31 | $0.27 B | -3.99% |
2019-12-31 | $0.29 B | 15.09% |
2018-12-31 | $0.25 B | 211.02% |
2017-12-31 | $81.22 M | 26.63% |
2016-12-31 | $64.14 M | 43.56% |
2015-12-31 | $44.67 M | 203.05% |
2014-12-31 | $14.74 M | 664.68% |
2013-12-31 | $1.92 M | -27.6% |
2012-12-31 | $2.66 M | -21.65% |
2011-12-31 | $3.39 M | -66% |
2010-12-31 | $9.99 M | -58.6% |
2009-12-31 | $24.14 M | 768.28% |
2008-12-31 | $2.78 M | -95.66% |
2007-12-31 | $64.07 M | 926.79% |
2006-12-31 | $6.24 M | -94.46% |
2005-12-31 | $0.11 B | 31.6% |
2004-12-31 | $85.64 M | |
2002-12-31 | $48.84 M | 815.54% |
2001-12-31 | $5.33 M |
Company | Total liabilities | differencediff. | Country |
---|---|---|---|
Ultragenyx RARE | $1.21 B | 250.16% | ๐บ๐ธ USA |
Spectrum Pharmaceuticals
SPPI | $80.87 M | -76.71% | ๐บ๐ธ USA |
Agenus
AGEN | $0.46 B | 33.17% | ๐บ๐ธ USA |